Kayla Kafka-Peterson RN BSN is a nurse from Los Angeles, California, USA. She provides operations leadership and oversight for the UCLA Department of Radiation Oncology HDR Brachytherapy Program and greater Radiation Oncology locations. Kayla coordinates all aspects of patient care, program operations, and is responsible for ongoing quality improvement, education and process development for the division. Kayla also teaches direct bedside patient care for nurses and teams. Since 2022, Kayla has worked to promote a global brachytherapy nursing and RTT community and works extensively with teams around the world providing brachytherapy nursing and team education. She also consults with physicians and teams on how to optimize efficiency, safety, and education for their brachytherapy programs to promote growth. Prior to working in brachytherapy, Kayla was a neuro/trauma ICU nurse. Kayla serves as the nursing liaison to the board of the American Brachytherapy Society and serves as the chair of the ABS Brachytherapy Nursing/Dosimetry/RTT Council. Kayla continues to collaborate with multiple medical societies and non-profit organizations on creating educational resources for brachytherapy nurses worldwide.

Find out more by visiting the Conference Program.

Dr. Kamrava is a radiation oncologist and Director of the Brachytherapy Division at Cedars Sinai Medical Center in Los Angeles. He is active in the use of brachytherapy for all disease sites. He is the current President of the American Brachytherapy Society and a past President of the Association for Directors of Radiation Oncology Programs. He serves as a Co-editor of the Gynecologic section for the Brachytherapy journal and as an editor of the Journal of Contemporary Brachytherapy. He is also a Co-editor of a Handbook on Image Guided Brachytherapy. He serves on the American Board of Radiology Gyn oral boards committee and is an oral boards examiner. He has also served on the National Cancer Institute Gynecologic Cancer Steering Committee. He has published over 150 peer reviewed manuscripts and been an author on multiple brachytherapy consensus guidelines (breast, prostate, cervical, skin, sarcoma). He has given lectures on brachytherapy topics at many national and international conferrences.

Find out more by visiting the Conference Program.

Dr. Shirin Abbasinejad Enger is a Full Professor in the Department of Oncology at McGill University, where she holds a Tier II Canada Research Chair in Medical Physics and serves as Director of the Medical Physics Unit as well as the Graduate Program Director. She received her Ph.D. in Medical Radiation Physics from Uppsala University, Sweden, in 2009, followed by a postdoctoral fellowship at Université Laval in 2011. Dr. Enger leads a multidisciplinary research program spanning four areas: brachytherapy technology, radiobiology and microdosimetry, detector innovation, and artificial intelligence in oncology. Her team develops advanced treatment planning systems, novel radiation sources, state-of-the-art detectors, and AI-enabled platforms to advance precision cancer treatment and improve patient outcomes. She has authored numerous peer-reviewed publications, holds multiple patents, and has made significant contributions to innovation and advancements in medical physics.

Find out more by visiting the Conference Program.